An AI Platform integrating imaging data and models, supporting precision care through prostate cancer’s continuum
Editorial by Manuel Marfil (on behalf of GIBI230: Research Group on Biomedical Imaging of Instituto de Investigación Sanitaria La Fe, HULAFE) Grounded in Evidence: building trust through Clinical Validation After more than three years of the ProCAncer-I, an EU funded...
Jurgita Usinskiene (dr. chief radiologist), Kristina Slidevska (radiation oncologist), Audrius Untanas (radiologist); National Cancer Institute, Vilnius, Lithuania Clinical Challenge: Artificial Intelligence-Powered Prediction of Prostate Cancer Treatment Response...
Βy Prof. Daniele Regge, Chief of the Radiology Unit and Simone Mazzetti; Candiolo Cancer Institute, Torino-Italy Presentation of the AI-QUAL study Magnetic resonance imaging (MRI) has become an essential tool in the diagnosis and management of patients with...
Interview with Dr. Kai Vilanova, Director MRI Clínica Girona, Coordinator Radiology, Faculty of Medicine, University of Girona. Director School of MRI-ESMRMB (IDIBGI) and Prof. Dow-Mu Koh, MD., M.R.C.P., F.R.C.R. Professor in Functional Cancer Imaging, Consultant...
Agios Savvas (St Savvas) The Hellenic Cancer Institute (HCI) was founded in 1935 by the "Christian Social Union". One of the first works of HCI was the establishment and operation of the "Agios Savvas" hospital (Geniko Antikarkiniko Ogkologiko Nosokomeio...
The Institut Paoli-Calmettes (IPC) Cancer Center Based in Marseille, The Institut Paoli-Calmettes (IPC) Cancer Center has been certified Comprehensive Cancer Center by OECI (Organisation of European Cancer Institutes) in June 2019 and then in June 2024. The IPC...
Newsletter #7 Contents
Prostate cancer can vary greatly in how aggressive it is, and knowing this in advance helps doctors decide the best course of treatment. Magnetic resonance imaging (MRI) is often used to detect prostate cancer, but figuring out just how aggressive the cancer is...
We are delighted to invite you to our session, “ProCAncer-I: An AI Platform Integrating Multiparametric MRI and AI Models”, at the European Congress of Radiology (ECR) 2025. Date: 26 February 2025 Time: 15:00 – 16:00 Location: ECR 2025, Vienna, Austria (conference...
ProCAncer-I will organise a Dedicated Session on the project during the European Congress of Radiology 2025 on the 26th of February 2025, at 15.00-16.00, with the title "ProCAncer-I: an AI platform integrating multiparametric MRI and AI models" where we will present...
Harnessing Big Data for the Future of Healthcare: Innovative Solutions with EUCAIM, ProCAncer-I, and European Health Data Spaces